公司資料
Vir Biotechnology 股價、新聞與催化劑
- 股票代碼:
- VIR
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
9.91 USD (+1.33%)
收盤價
最後更新: 2026年8月24日
1.47B USD
市值
股價為何變動
As of Aug 24, 2026, VIR closed up 1.33% at $9.91. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Vir Biotechnology is an immunology and infectious-disease company built around antibody science and platform partnerships.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Vir sits in specialty biotechnology.
商業模式特徵
Its model depends on clinical development, collaboration revenue, and finding durable programs beyond the pandemic era.
生技產業定位
Vir remains a platform-heavy biotech name, but investors need the pipeline to deliver clear differentiation to keep the story moving.
未來催化劑
- Vir Biotechnology's catalysts are tobevibart plus elebsiran in hepatitis D, along with the rest of the hepatitis B franchise. The stock will care about whether the antiviral platform can keep finding a clear regulatory and commercial path.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。